Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statementJoerg Herrmann, Peter Valent, Anne Blaes et al.|European Heart Journal|2021Cited by 589
Innate immune signaling drives late cardiac toxicity following DNA-damaging cancer therapiesA. Shamseddine, Adam M. Schmitt, Suchit H. Patel et al.|The Journal of Experimental Medicine|2022Cited by 26